Novo Nordisk

Pfizer Just Canned One of Its Ozempic Killers. What's Next?
Motley Fool
Mon, 07/3/23 - 10:37 am
Pfizer
obesity
lotiglipron
danuglipron
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
obesity
clinical trials
Novo Nordisk
Altimmune
Innovent Biologics
Pfizer
Shionogi
Tonix
semaglutide
oxytocin
permvidutide
mazdutide
danuglipron
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Wed, 06/28/23 - 11:44 am
FDA
clinical trials
Sarepta Therapeutics
Bridge Bio
Sanofi
Merck KGaA
Pfizer
Novo Nordisk
Verve Therapeutics
Roche
Vertex Pharmaceuticals
JNJ
Bristol Myers Squibb
ATTR-CM
Elevidys
tolebrutinib
evobrutinib
danuglipron
tiragolumab
VX-548
lazertinib
ADA 2023 – Lilly unveils its triple threat
EP Vantage
Wed, 06/28/23 - 09:57 am
Eli Lilly
Novo Nordisk
retatrutide
Wegovy
Mounjaro
obesity
clinical trials
Novo Nordisk's phase 3 data for hemophilia hopeful fail to shake off Pfizer's shadow
Fierce Biotech
Tue, 06/27/23 - 10:36 pm
Novo Nordisk
hemophilia
clinical trials
Pfizer
Roche
Hemlibra
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Mon, 06/26/23 - 10:00 am
Eli Lilly
obesity
orforglipron
Pfizer
Novo Nordisk
Mounjaro
Novo Nordisk’s once-weekly insulin supersedes its once-daily counterparts
Clinical Trials Arena
Mon, 06/26/23 - 09:54 am
Novo Nordisk
clinical trials
insulin
Icodec
Novo Nordisk says EMA raised safety signal on drugs including semaglutide
Yahoo/Reuters
Thu, 06/22/23 - 10:21 am
Novo Nordisk
EMA
semaglutide
Ozempic
Wegovy
thyroid cancer
obesity
diabetes
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
CNBC
Tue, 06/20/23 - 09:54 pm
Novo Nordisk
legal
Ozempic
Wegocy
knockoffs
Eli Lilly's Mounjaro is primed to surpass Novo Nordisk's popular diabetes and obesity duo: report
Fierce Pharma
Mon, 06/19/23 - 10:29 am
Eli Lilly
Novo Nordisk
Mounjaro
semaglutide
diabetes
obesity
More payers could stanch off-label use of Ozempic
Medical Marketing and Media
Mon, 06/19/23 - 10:24 am
Novo Nordisk
Ozempic
off-label
weight loss
Ro pauses advertising of weight loss drug Wegovy amid shortages
Stat
Mon, 06/12/23 - 11:34 pm
telehealth
Novo Nordisk
Wegovy
pharma advertising
Novo Nordisk to invest over $2B in drug ingredient production
BioPharma Dive
Mon, 06/12/23 - 11:21 pm
Novo Nordisk
drug manufacturing
Novo Nordisk Eyes a Bigger Piece of the Diabetes Market
Medical Devices and Diagnostics Industry
Tue, 06/6/23 - 04:13 pm
Novo Nordisk
Biocorp
Bio Jag
diabetes
Novo Nordisk enters talks to buy device maker Biocorp
Medical Marketing and Media
Mon, 06/5/23 - 11:30 am
Novo Nordisk
M&A
Medtech
Biocorp
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Mon, 06/5/23 - 10:07 am
Pfizer
danuglipron
Novo Nordisk
Ozempic
weight loss
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement
Medwatch
Sun, 06/4/23 - 04:19 pm
Novo Nordisk
insulin
diabetes
drug pricing
Novo Nordisk wins age discrimination case in US district court
Medwatch
Sun, 06/4/23 - 04:17 pm
Novo Nordisk
age discrimination
legal
EEOC
Novo seeks a cardiovascular boost
EP Vantage
Thu, 06/1/23 - 11:23 am
Novo Nordisk
Wegovy
Eli Lilly
Mounjaro
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
Wed, 05/31/23 - 11:08 am
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen

Pages